In addition, analyses of GSE21034 and GSE35988 databases revealed that GLUT1 expression was augmented in metastatic prostate cancer in men relative to that in primary prostate cancer, a trend consistent with SMC4 expression (Figure 8G). Here, SLC2A1 is linked to prostate carcinoma.